Cour Pharmaceuticals lands $105 million for next phase of clinical trials

Cour Pharmaceuticals raised new financing this week to help reprogram the way the immune system works.

Alex Zorn

Source link

How to turn a supermarket bouquet into a lusher, more personalized flower arrangement

If your heart is telling you to give someone a luxurious bouquet…

Meghan’s BUSINESS fail – Nigerian BOOED Sussex after LIED 43%, Harry MISSED…

HelloFresh’s value surged early in the pandemic. The company has fallen back…

Primary day is May 14, with polls open from 7 a.m. to…